- Home
- RYTM vs PFSI Comparison
RYTM vs PFSI Comparison
Compare RYTM & PFSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYTM
- PFSI
- Stock Information
- Founded
- RYTM 2008
- PFSI 2008
- Country
- RYTM United States
- PFSI United States
- Employees
- RYTM N/A
- PFSI N/A
- Industry
- RYTM Biotechnology: Pharmaceutical Preparations
- PFSI Finance: Consumer Services
- Sector
- RYTM Health Care
- PFSI Finance
- Exchange
- RYTM Nasdaq
- PFSI Nasdaq
- Market Cap
- RYTM 6.4B
- PFSI 6.5B
- IPO Year
- RYTM 2017
- PFSI 2013
- Fundamental
- Price
- RYTM $98.54
- PFSI $129.27
- Analyst Decision
- RYTM Strong Buy
- PFSI Buy
- Analyst Count
- RYTM 12
- PFSI 6
- Target Price
- RYTM $117.00
- PFSI $138.67
- AVG Volume (30 Days)
- RYTM 629.6K
- PFSI 348.0K
- Earning Date
- RYTM 11-04-2025
- PFSI 10-21-2025
- Dividend Yield
- RYTM N/A
- PFSI 0.93%
- EPS Growth
- RYTM N/A
- PFSI 191.00
- EPS
- RYTM N/A
- PFSI 9.30
- Revenue
- RYTM $174,334,000.00
- PFSI $2,723,457,000.00
- Revenue This Year
- RYTM $46.10
- PFSI $8.04
- Revenue Next Year
- RYTM $63.02
- PFSI $26.50
- P/E Ratio
- RYTM N/A
- PFSI $13.89
- Revenue Growth
- RYTM 54.92
- PFSI 21.25
- 52 Week Low
- RYTM $45.91
- PFSI $85.74
- 52 Week High
- RYTM $116.00
- PFSI $134.56
- Technical
- Relative Strength Index (RSI)
- RYTM 39.87
- PFSI 61.01
- Support Level
- RYTM $95.27
- PFSI $122.00
- Resistance Level
- RYTM $102.20
- PFSI $130.55
- Average True Range (ATR)
- RYTM 4.86
- PFSI 3.30
- MACD
- RYTM -1.75
- PFSI -0.01
- Stochastic Oscillator
- RYTM 17.51
- PFSI 61.84
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.
About PFSI PennyMac Financial Services Inc.
PennyMac Financial Services Inc is a specialty financial services firm with a comprehensive mortgage platform and integrated business focused on the production and servicing of U.S. residential mortgage loans. The company operates through two segments: production and servicing. The production segment performs loan origination, acquisition and sale activities. The servicing segment performs loan servicing for newly originated loans.